⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for stage iiia gastric cancer

Every month we try and update this database with for stage iiia gastric cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal CancerNCT00274885
Cancer
oxaliplatin
management of t...
18 Years - National Cancer Institute (NCI)
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung CancersNCT01846520
Healthy Subject
Localized Trans...
Metastatic Tran...
Psychosocial Ef...
Recurrent Bladd...
Recurrent Cervi...
Recurrent Colon...
Recurrent Gastr...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Recta...
Recurrent Renal...
Recurrent Trans...
Recurrent Ureth...
Recurrent Uteri...
Regional Transi...
Stage II Bladde...
Stage II Renal ...
Stage II Urethr...
Stage IIA Cervi...
Stage IIA Colon...
Stage IIA Gastr...
Stage IIA Ovari...
Stage IIA Ovari...
Stage IIA Pancr...
Stage IIA Recta...
Stage IIA Uteri...
Stage IIB Cervi...
Stage IIB Colon...
Stage IIB Gastr...
Stage IIB Ovari...
Stage IIB Ovari...
Stage IIB Pancr...
Stage IIB Recta...
Stage IIB Uteri...
Stage IIC Colon...
Stage IIC Ovari...
Stage IIC Ovari...
Stage IIC Recta...
Stage III Bladd...
Stage III Pancr...
Stage III Renal...
Stage III Ureth...
Stage IIIA Cerv...
Stage IIIA Colo...
Stage IIIA Gast...
Stage IIIA Ovar...
Stage IIIA Ovar...
Stage IIIA Rect...
Stage IIIA Uter...
Stage IIIB Cerv...
Stage IIIB Colo...
Stage IIIB Gast...
Stage IIIB Ovar...
Stage IIIB Ovar...
Stage IIIB Rect...
Stage IIIB Uter...
Stage IIIC Colo...
Stage IIIC Gast...
Stage IIIC Ovar...
Stage IIIC Ovar...
Stage IIIC Rect...
Stage IIIC Uter...
Stage IV Bladde...
Stage IV Gastri...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Renal ...
Stage IV Urethr...
Stage IVA Cervi...
Stage IVA Colon...
Stage IVA Recta...
Stage IVA Uteri...
Stage IVB Cervi...
Stage IVB Colon...
Stage IVB Recta...
Stage IVB Uteri...
Ureter Cancer
Stage IIA Lung ...
Stage IIB Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
educational int...
telephone-based...
quality-of-life...
questionnaire a...
18 Years - City of Hope Medical Center
64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric CancerNCT01939275
Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Recurrent Gastr...
Stage IA Gastri...
Stage IB Gastri...
Stage IIA Gastr...
Stage IIB Gastr...
Stage IIIA Gast...
Stage IIIB Gast...
Stage IIIC Gast...
Stage IV Gastri...
copper Cu 64-DO...
positron emissi...
laboratory biom...
Computed Tomogr...
18 Years - City of Hope Medical Center
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionNCT00938470
Adenocarcinoma ...
Esophageal Canc...
Gastric Cancer
capecitabine
docetaxel
fluorouracil
oxaliplatin
radiation thera...
therapeutic con...
18 Years - Alliance for Clinical Trials in Oncology
64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric CancerNCT01939275
Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Recurrent Gastr...
Stage IA Gastri...
Stage IB Gastri...
Stage IIA Gastr...
Stage IIB Gastr...
Stage IIIA Gast...
Stage IIIB Gast...
Stage IIIC Gast...
Stage IV Gastri...
copper Cu 64-DO...
positron emissi...
laboratory biom...
Computed Tomogr...
18 Years - City of Hope Medical Center
Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach CancerNCT01212822
Adenocarcinoma ...
Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Squamous Cell C...
Stage IA Esopha...
Stage IA Gastri...
Stage IB Esopha...
Stage IB Gastri...
Stage IIA Esoph...
Stage IIA Gastr...
Stage IIB Esoph...
Stage IIB Gastr...
Stage IIIA Esop...
Stage IIIA Gast...
Stage IIIB Esop...
Stage IIIB Gast...
Stage IIIC Esop...
Stage IIIC Gast...
bevacizumab
oxaliplatin
leucovorin calc...
fluorouracil
therapeutic con...
laboratory biom...
18 Years - Fox Chase Cancer Center
Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach CancerNCT00978549
Adenocarcinoma ...
Esophageal Canc...
Gastric Cancer
Nausea and Vomi...
Pain
docetaxel
steroid therapy
questionnaire a...
nausea and vomi...
pain therapy
quality-of-life...
standard follow...
radiation thera...
18 Years - National Cancer Institute (NCI)
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal MalignanciesNCT01643499
Acinar Cell Ade...
Adenocarcinoma ...
Adenocarcinoma ...
Adult Primary C...
Advanced Adult ...
Cholangiocarcin...
Cholangiocarcin...
Diffuse Adenoca...
Duct Cell Adeno...
Intestinal Aden...
Localized Unres...
Metastatic Carc...
Metastatic Extr...
Mixed Adenocarc...
Mucinous Adenoc...
Mucinous Adenoc...
Newly Diagnosed...
Signet Ring Ade...
Signet Ring Ade...
Stage III Pancr...
Stage IIIA Colo...
Stage IIIA Gall...
Stage IIIA Gast...
Stage IIIA Rect...
Stage IIIB Colo...
Stage IIIB Gall...
Stage IIIB Gast...
Stage IIIB Rect...
Stage IIIC Colo...
Stage IIIC Gast...
Stage IIIC Rect...
Stage IV Gastri...
Stage IV Pancre...
Stage IVA Colon...
Stage IVA Gallb...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Gallb...
Stage IVB Recta...
Unresectable Ex...
oxaliplatin
irinotecan hydr...
leucovorin calc...
fluorouracil
laboratory biom...
18 Years - University of Chicago
Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaNCT00084604
Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Recurrent Gastr...
Stage IIIA Gast...
Stage IIIB Gast...
Stage IIIC Gast...
Stage IV Gastri...
irinotecan hydr...
bevacizumab
cisplatin
computed tomogr...
laboratory biom...
18 Years - National Cancer Institute (NCI)
A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction CancerNCT00064259
Adenocarcinoma ...
Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Recurrent Esoph...
Recurrent Gastr...
Squamous Cell C...
Stage III Esoph...
Stage IIIA Gast...
Stage IIIB Gast...
Stage IIIC Gast...
Stage IV Esopha...
Stage IV Gastri...
oblimersen sodi...
cisplatin
fluorouracil
19 Years - National Cancer Institute (NCI)
A Study of Creatine Combined With Curcumin in the Intervention of Early Cachexia in Upper Gastrointestinal TumorsNCT05856500
Stage IV Gastri...
Stage IIIA Gast...
Stage IIIB Gast...
Stage III Esoph...
Stage IV Esopha...
basic nutrition
oral supplement...
18 Years - 80 YearsThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal CancerNCT02333188
Adenocarcinoma ...
Adult Cholangio...
Gallbladder Car...
Gastric Adenoca...
Malignant Gastr...
Metastatic Panc...
Pancreatic Aden...
Stage III Ampul...
Stage III Pancr...
Stage IIIA Gall...
Stage IIIA Gast...
Stage IIIB Gall...
Stage IIIB Gast...
Stage IV Ampull...
Stage IV Gallbl...
Stage IV Gastri...
Stage IV Pancre...
Paclitaxel Albu...
Leucovorin Calc...
Irinotecan Hydr...
Fluorouracil
Laboratory Biom...
18 Years - University of Chicago
Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal JunctionNCT01360086
Adenocarcinoma ...
Gastric Cancer
cetuximab
cisplatin
fluorouracil
leucovorin calc...
adjuvant therap...
neoadjuvant the...
quality-of-life...
therapeutic con...
18 Years - 75 YearsFederation Francophone de Cancerologie Digestive
64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric CancerNCT01939275
Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Recurrent Gastr...
Stage IA Gastri...
Stage IB Gastri...
Stage IIA Gastr...
Stage IIB Gastr...
Stage IIIA Gast...
Stage IIIB Gast...
Stage IIIC Gast...
Stage IV Gastri...
copper Cu 64-DO...
positron emissi...
laboratory biom...
Computed Tomogr...
18 Years - City of Hope Medical Center
A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction CancerNCT00064259
Adenocarcinoma ...
Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Recurrent Esoph...
Recurrent Gastr...
Squamous Cell C...
Stage III Esoph...
Stage IIIA Gast...
Stage IIIB Gast...
Stage IIIC Gast...
Stage IV Esopha...
Stage IV Gastri...
oblimersen sodi...
cisplatin
fluorouracil
19 Years - National Cancer Institute (NCI)
Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction CancerNCT00963092
Adenocarcinoma ...
Esophageal Canc...
Gastric Cancer
DNA analysis
RNA analysis
microarray anal...
protein analysi...
cytology specim...
laboratory biom...
questionnaire a...
16 Years - National Cancer Institute (NCI)
Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach CancerNCT00978549
Adenocarcinoma ...
Esophageal Canc...
Gastric Cancer
Nausea and Vomi...
Pain
docetaxel
steroid therapy
questionnaire a...
nausea and vomi...
pain therapy
quality-of-life...
standard follow...
radiation thera...
18 Years - National Cancer Institute (NCI)
Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction CancerNCT01123473
Adenocarcinoma ...
Gastric Cancer
capecitabine
cisplatin
epirubicin hydr...
fluorouracil
lapatinib ditos...
18 Years - 75 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal CancerNCT02344810
Adenocarcinoma ...
Adenocarcinoma ...
Diffuse Adenoca...
Gastrointestina...
Intestinal Aden...
Mixed Adenocarc...
Stage IIIA Esop...
Stage IIIA Gast...
Stage IIIB Esop...
Stage IIIB Gast...
Stage IIIC Esop...
Stage IIIC Gast...
Stage IV Esopha...
Stage IV Gastri...
c-Met inhibitor...
placebo
oxaliplatin
leucovorin calc...
fluorouracil
pharmacological...
laboratory biom...
18 Years - Eastern Cooperative Oncology Group
Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction CancerNCT00982592
Adenocarcinoma ...
Adenocarcinoma ...
Recurrent Gastr...
Stage IIIA Gast...
Stage IIIB Gast...
Stage IIIC Gast...
Stage IV Gastri...
oxaliplatin
leucovorin calc...
fluorouracil
placebo
vismodegib
laboratory biom...
18 Years - National Cancer Institute (NCI)
Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction CancerNCT00963092
Adenocarcinoma ...
Esophageal Canc...
Gastric Cancer
DNA analysis
RNA analysis
microarray anal...
protein analysi...
cytology specim...
laboratory biom...
questionnaire a...
16 Years - National Cancer Institute (NCI)
Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach CancerNCT01212822
Adenocarcinoma ...
Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Squamous Cell C...
Stage IA Esopha...
Stage IA Gastri...
Stage IB Esopha...
Stage IB Gastri...
Stage IIA Esoph...
Stage IIA Gastr...
Stage IIB Esoph...
Stage IIB Gastr...
Stage IIIA Esop...
Stage IIIA Gast...
Stage IIIB Esop...
Stage IIIB Gast...
Stage IIIC Esop...
Stage IIIC Gast...
bevacizumab
oxaliplatin
leucovorin calc...
fluorouracil
therapeutic con...
laboratory biom...
18 Years - Fox Chase Cancer Center
Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing SurgeryNCT02511821
Stage I Adult L...
Stage I Colorec...
Stage IA Gastri...
Stage IA Pancre...
Stage IB Gastri...
Stage IB Pancre...
Stage II Adult ...
Stage IIA Color...
Stage IIA Gastr...
Stage IIA Pancr...
Stage IIB Color...
Stage IIB Gastr...
Stage IIB Pancr...
Stage IIC Color...
Stage III Pancr...
Stage IIIA Adul...
Stage IIIA Colo...
Stage IIIA Gast...
Stage IIIB Adul...
Stage IIIB Colo...
Stage IIIB Gast...
Stage IIIC Adul...
Stage IIIC Colo...
Stage IIIC Gast...
Stage IV Gastri...
Stage IVA Color...
Stage IVA Liver...
Stage IVA Pancr...
Stage IVB Color...
Stage IVB Liver...
Stage IVB Pancr...
Computer-Assist...
Vivofit watch
Quality-of-Life...
Questionnaire A...
21 Years - City of Hope Medical Center
Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By SurgeryNCT00991952
Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Recurrent Gastr...
Stage IIIA Gast...
Stage IIIB Gast...
Stage IIIC Gast...
Stage IV Gastri...
alvocidib
irinotecan hydr...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaNCT00084604
Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Recurrent Gastr...
Stage IIIA Gast...
Stage IIIB Gast...
Stage IIIC Gast...
Stage IV Gastri...
irinotecan hydr...
bevacizumab
cisplatin
computed tomogr...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal MalignanciesNCT01643499
Acinar Cell Ade...
Adenocarcinoma ...
Adenocarcinoma ...
Adult Primary C...
Advanced Adult ...
Cholangiocarcin...
Cholangiocarcin...
Diffuse Adenoca...
Duct Cell Adeno...
Intestinal Aden...
Localized Unres...
Metastatic Carc...
Metastatic Extr...
Mixed Adenocarc...
Mucinous Adenoc...
Mucinous Adenoc...
Newly Diagnosed...
Signet Ring Ade...
Signet Ring Ade...
Stage III Pancr...
Stage IIIA Colo...
Stage IIIA Gall...
Stage IIIA Gast...
Stage IIIA Rect...
Stage IIIB Colo...
Stage IIIB Gall...
Stage IIIB Gast...
Stage IIIB Rect...
Stage IIIC Colo...
Stage IIIC Gast...
Stage IIIC Rect...
Stage IV Gastri...
Stage IV Pancre...
Stage IVA Colon...
Stage IVA Gallb...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Gallb...
Stage IVB Recta...
Unresectable Ex...
oxaliplatin
irinotecan hydr...
leucovorin calc...
fluorouracil
laboratory biom...
18 Years - University of Chicago
Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach CancerNCT01212822
Adenocarcinoma ...
Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Squamous Cell C...
Stage IA Esopha...
Stage IA Gastri...
Stage IB Esopha...
Stage IB Gastri...
Stage IIA Esoph...
Stage IIA Gastr...
Stage IIB Esoph...
Stage IIB Gastr...
Stage IIIA Esop...
Stage IIIA Gast...
Stage IIIB Esop...
Stage IIIB Gast...
Stage IIIC Esop...
Stage IIIC Gast...
bevacizumab
oxaliplatin
leucovorin calc...
fluorouracil
therapeutic con...
laboratory biom...
18 Years - Fox Chase Cancer Center
Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric CancerNCT00985556
Gastric Cancer
capecitabine
oxaliplatin
tegafur-gimerac...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: